Latest Breaking News On - Chief executive officerof acesion - Page 1 : comparemela.com

Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation

/PRNewswire/ Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering first-in-class novel therapies for atrial fibrillation ("AF"), the.

Acesion pharmaAnders gaarsdal holstNovo holdingsGlobal bioaccess fundNature medicineGaarsdal holstChief executive officerof acesionAlpha wave venturesWellcome trustBroadview venturesNew england journal

Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation

Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New south walesCity ofUnited kingdomNew yorkUnited statesTel avivJakarta rayaAcesion pharmaNovo nordiskAbu dhabiPrnewswire acesion pharmaNavroz udwadiaAnders gaarsdal holstNik economopoulosErick gersonRyan khoury

Acesion Pharma Announces Positive Pre-Clinical Data for AP31969

/PRNewswire/ Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering first-in-class novel therapies for atrial fibrillation ("AF"), the.

Anders gaarsdal holstPrnewswire acesion pharmaAcesion pharmaNovo holdingsGaarsdal holstChief executive officerof acesionWellcome trustBroadview venturesNew england journal